CMND
Price
$1.95
Change
-$0.15 (-7.14%)
Updated
Feb 4, 02:24 PM (EDT)
Capitalization
3.15M
Intraday BUY SELL Signals
NEUP
Price
$3.97
Change
-$0.06 (-1.49%)
Updated
Feb 4, 03:00 PM (EDT)
Capitalization
21.46M
Intraday BUY SELL Signals
Interact to see
Advertisement

CMND vs NEUP

Header iconCMND vs NEUP Comparison
Open Charts CMND vs NEUPBanner chart's image
Clearmind Medicine
Price$1.95
Change-$0.15 (-7.14%)
Volume$103
Capitalization3.15M
Neuphoria Therapeutics
Price$3.97
Change-$0.06 (-1.49%)
Volume$100
Capitalization21.46M
CMND vs NEUP Comparison Chart in %
CMND
Daily Signal:
Gain/Loss:
NEUP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CMND vs. NEUP commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMND is a Hold and NEUP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CMND: $2.10 vs. NEUP: $4.03)
Brand notoriety: CMND and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMND: 37% vs. NEUP: 39%
Market capitalization -- CMND: $3.15M vs. NEUP: $21.46M
CMND [@Biotechnology] is valued at $3.15M. NEUP’s [@Biotechnology] market capitalization is $21.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMND’s FA Score shows that 1 FA rating(s) are green whileNEUP’s FA Score has 2 green FA rating(s).

  • CMND’s FA Score: 1 green, 4 red.
  • NEUP’s FA Score: 2 green, 3 red.
According to our system of comparison, both CMND and NEUP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMND’s TA Score shows that 4 TA indicator(s) are bullish while NEUP’s TA Score has 2 bullish TA indicator(s).

  • CMND’s TA Score: 4 bullish, 2 bearish.
  • NEUP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CMND is a better buy in the short-term than NEUP.

Price Growth

CMND (@Biotechnology) experienced а -21.64% price change this week, while NEUP (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($21.5M) has a higher market cap than CMND($3.15M). NEUP has higher P/E ratio than CMND: NEUP (0.78) vs CMND (0.17). CMND YTD gains are higher at: 16.022 vs. NEUP (3.737). NEUP has higher annual earnings (EBITDA): -2.25M vs. CMND (-3.72M). NEUP has more cash in the bank: 13.6M vs. CMND (5.59M). NEUP has less debt than CMND: NEUP (118K) vs CMND (1.78M). NEUP has higher revenues than CMND: NEUP (15.6M) vs CMND (0).
CMNDNEUPCMND / NEUP
Capitalization3.15M21.5M15%
EBITDA-3.72M-2.25M165%
Gain YTD16.0223.737429%
P/E Ratio0.170.7822%
Revenue015.6M-
Total Cash5.59M13.6M41%
Total Debt1.78M118K1,508%
TECHNICAL ANALYSIS
Technical Analysis
CMNDNEUP
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 13 days ago
90%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CMND
Daily Signal:
Gain/Loss:
NEUP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMTD1.000.03
+2.58%
AMTD IDEA Group
FMNB13.160.14
+1.08%
Farmers National Banc Corp
ALG195.520.52
+0.27%
Alamo Group
IONQ38.47-0.09
-0.23%
IonQ
BBLG1.58-0.05
-3.07%
Bone Biologics Corp

CMND and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMND has been loosely correlated with CYTOF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CMND jumps, then CYTOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMND
1D Price
Change %
CMND100%
-5.83%
CYTOF - CMND
41%
Loosely correlated
N/A
RZLT - CMND
37%
Loosely correlated
-2.78%
HURA - CMND
37%
Loosely correlated
-10.04%
SLGL - CMND
37%
Loosely correlated
+2.47%
CDT - CMND
32%
Poorly correlated
+19.82%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with BRNS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-0.37%
BRNS - NEUP
50%
Loosely correlated
+2.76%
GLPG - NEUP
35%
Loosely correlated
+1.08%
SLGL - NEUP
33%
Poorly correlated
+2.47%
CMND - NEUP
33%
Poorly correlated
-5.83%
INBX - NEUP
32%
Poorly correlated
+3.47%
More